Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market ... - Sacramento Bee
Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market .
Progress report on the first sub-Saharan trial of newer versus older ... - 7thSpace Interactive (press release)
Progress report on the first sub-Saharan trial of newer versus older .
Novartis: A Sleeper Or A Headache? - Seeking Alpha
Novartis: A Sleeper Or A Headache?Seeking AlphaThis last quarter, Novartis missed the street estimates mainly because of looming patent expiration of some of their best-selling prescription drugs, most notably Diovan (valsartan).
Novartis expands in generics with $1.53bn Fougera buy - PMLiVE
Novartis expands in generics with $1.
Novartis Pressures Generics Makers Over Exforge ANDA - Law360 (subscription)
Novartis Pressures Generics Makers Over Exforge ANDALaw360 (subscription).